Lucid Diagnostics Inc. Short Interest Up 16.4 percent in January - MarketBeat
LUCD Stock | USD 0.79 0.02 2.60% |
About 58% of all Lucid Diagnostics' shareholders are looking to take a long position. The analysis of overall sentiment of trading Lucid Diagnostics stock suggests that some investors are interested at this time. The current market sentiment, together with Lucid Diagnostics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lucid Diagnostics stock news signals to limit their universe of possible portfolio assets.
Lucid |
Lucid Diagnostics Inc. Short Interest Up 16.4 percent in January MarketBeat
Read at news.google.com
Lucid Diagnostics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Lucid Diagnostics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Lucid Diagnostics Fundamental Analysis
We analyze Lucid Diagnostics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lucid Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lucid Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Lucid Diagnostics is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Lucid Diagnostics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lucid Diagnostics stock to make a market-neutral strategy. Peer analysis of Lucid Diagnostics could also be used in its relative valuation, which is a method of valuing Lucid Diagnostics by comparing valuation metrics with similar companies.
Peers
Lucid Diagnostics Related Equities
FNA | Paragon 28 | 1.86 | ||||
NPCE | Neuropace | 1.10 | ||||
KIDS | Orthopediatrics Corp | 0.91 | ||||
LUNG | Pulmonx Corp | 0.83 | ||||
SRDX | SurModics | 0.10 | ||||
ITGR | Integer Holdings | 0.42 | ||||
OFIX | Orthofix Medical | 0.72 | ||||
LIVN | LivaNova PLC | 1.17 | ||||
NARI | Inari Medical | 1.35 | ||||
ELMD | Electromed | 1.47 | ||||
IRMD | Iradimed | 3.31 | ||||
XAIR | Beyond Air | 4.08 | ||||
CVRX | CVRx | 4.25 | ||||
CLPT | Clearpoint Neuro | 6.52 |
Complementary Tools for Lucid Stock analysis
When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stocks Directory Find actively traded stocks across global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |